Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL

Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL

Jing Zhang, Yan Gu, Baoan Chen Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People’s Republic of ChinaCorrespondence: Baoan Chen, Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, People’s...

Full description

Bibliographic Details
Main Authors: Zhang J, Gu Y, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2023-02-01
Series:Cancer Management and Research
Subjects:
relapse and refractory dlbcl
drug resistance
targeted therapy
cd47
nf-κb
car-t therapy
antibody drug-conjugate
Online Access:https://www.dovepress.com/drug-resistance-mechanism-and-new-targeted-drugs-and-treatments-of-rel-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/drug-resistance-mechanism-and-new-targeted-drugs-and-treatments-of-rel-peer-reviewed-fulltext-article-CMAR

Similar Items